[HTML][HTML] Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients
CE Chamberlain, SR Penzak, RM Alfaro… - American Journal of …, 2008 - Elsevier
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
[引用][C] Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients
C CE - Am J Transplant, 2008 - cir.nii.ac.jp
Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients
CE Chamberlain, SR Penzak… - … : official journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients
CE Chamberlain, SR Penzak… - American Journal of …, 2008 - experts.nebraska.edu
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
[HTML][HTML] Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients
CE Chamberlain, SR Penzak, RM Alfaro… - American journal of …, 2008 - ncbi.nlm.nih.gov
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
[HTML][HTML] Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients
CE Chamberlain, SR Penzak, RM Alfaro… - American Journal of …, 2008 - amjtransplant.org
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients
CE Chamberlain, SR Penzak, RM Alfaro… - American Journal of …, 2008 - Wiley Online Library
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients.
CE Chamberlain, SR Penzak, RM Alfaro… - American Journal of …, 2008 - europepmc.org
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
[引用][C] Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients
CE CHAMBERLAIN, SR PENZAK… - American journal of …, 2008 - pascal-francis.inist.fr
Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant
Recipients CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Recipients CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients.
CE Chamberlain, SR Penzak, RM Alfaro, R Wesley… - 2008 - cabidigitallibrary.org
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …
patients. A fixed dose of 900 mg daily is typically recommended, however, there has never …